Monovisc 88 MG/4 ML syringe 4ML
Ended Awarded Last action
- Contract number
- SPE2DR26F13GQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,857
Award facts
- Contract value 100% obligated
- $1,857.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Monovisc 88 mg/4 ml syringes with a ceiling value of $1,857.18. This is a firm fixed price delivery order with an ultimate completion date of December 12, 2025, and represents a non-competitive, non-set-aside award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.99 billion and extends through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Through this contract vehicle and related agreements, AmerisourceBergen serves multiple federal healthcare customers including the Defense Health Agency and U.S. Coast Guard, positioning the company as a key vendor within the DLA's strategic pharmaceutical procurement framework.
Quick answers
Who was awarded contract SPE2DR26F13GQ?
SPE2DR26F13GQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26F13GQ worth?
The government has obligated $1,857 on SPE2DR26F13GQ.
Is contract SPE2DR26F13GQ an order under another contract?
Yes. SPE2DR26F13GQ is a delivery order under SPE2DR25D1110, an indefinite delivery contract.
Was contract SPE2DR26F13GQ competed?
The extent of competition for SPE2DR26F13GQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award